We are doing a study to learn about the beliefs current and former cigarillo users have about smoking and quitting cigarillos.

This study compares two dose strengths of a new epilepsy medicine to placebo for treatment of refractory focal onset epilepsy as measured by the change in 28-day average seizure frequency.

The presence of certain genetic factors in some patients protects them from developing coronary artery disease (CAD). This study seeks to identify these protective genetic factors and to expand our understanding of the genetic contribution to the development of CAD.

The purpose of this study is to qualitatively examine how social movements and actors within social movement organizations interact with the press and media as they work to achieve their goals. This study seeks to further examine the relationship between left-leaning social movements in the U.S. South as alternative media outlets and newspapers decline and tension between social movements and actors like the state and elected officials intensify.

We intend to study sensations generated by spinal cord stimulation with the goal of using this knowledge to develop electrical interfaces that can restore loss of sensory function after neurological injury or disease.

To understand how people act towards those who hold different beliefs than them.

This is a multicenter, open-label study to study the safety and characteristics of DNL310, an investigational drug designed to treat both the body and brain manifestations of Mucopolysaccharidosis type II (MPS II; Hunter syndrome). The plan is for each participant to start at a low dose and increase over time until a final dose is achieved. Blood, urine and CSF samples will be taken, and tests and assessments will be done to see how your child is doing in the study.

The overall goal of the UNC CFAR is to support research of HIV infection carried out by UNC CFAR affiliated investigators and collaborators outside UNC. In order to achieve the goal of providing cutting edge research and testing services, the UNC CFAR will use samples of blood, hair, urine, oral and genital secretions from HIV seropositive and seronegative donors to evaluate, validate and quality control current and future assays.

To explore expression of tolerance for ambiguity and need for definitive conclusion among medical students and to compare these scores across time in medical school.

To determine whether newly-developed naloxone training materials increase how often pharmacists dispense naloxone.